New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone

Affiliations

¹ From Cardiology Unit, Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden. lars.ryden@ki.se.
² From Cardiology Unit, Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden.

Editorial

Lars Rydén et al. Circulation. 2017.

. 2017 May 16;135(20):1894-1896.

doi: 10.1161/CIRCULATIONAHA.117.027952.

¹ From Cardiology Unit, Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden. lars.ryden@ki.se.
² From Cardiology Unit, Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Keywords: Editorials; infarction; insulin resistance; preventive medicine.

Comment on

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
Young LH, Viscoli CM, Curtis JP, Inzucchi SE, Schwartz GG, Lovejoy AM, Furie KL, Gorman MJ, Conwit R, Abbott JD, Jacoby DL, Kolansky DM, Pfau SE, Ling FS, Kernan WN; IRIS Investigators. Young LH, et al. Circulation. 2017 May 16;135(20):1882-1893. doi: 10.1161/CIRCULATIONAHA.116.024863. Epub 2017 Feb 28. Circulation. 2017. PMID: 28246237 Free PMC article. Clinical Trial.